Toll-like Receptors in Innate Immunity

Measuring Immunity: Basic Biology and Clinical Assessment

Volumn , Issue , 2005, Pages 80-90

  Hawn, Thomas R ^a   Underhill, David M ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960062269     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012455900-4/50268-3     Document Type: Chapter

References (84)

1. Abel B., et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 2002, 169:3155-3162.
2. Abreu M.T., Arnold E.T., Thomas L.S., et al. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 2002, 277:20431-20437.
3. Agnese D.M., Calvano J.E., Hahm S.J., et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002, 186:1522-1525.
4. Anderson K.V. Toll signaling pathways in the innate immune response. Curr Opin Immunol 2000, 12:13-19.
5. Arbour N., Lorenz E., Schutte B., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000, 25:187-191.
6. Brightbill H.D., Libraty D.H., Krutzik S.R., et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999, 285:732-736.
7. Cario E., Podolsky D.K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000, 68:7010-7017.
8. Casanova J.L., Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002, 20:581-620.
9. Chuang T., Ulevitch R.J. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 2001, 1518:157-161.
10. Chuang T.H., Ulevitch R.J. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Cur Cytokine Netw 2000, 11:372-378.
11. Cooke G.S., Hill A.V. Genetics of susceptibility to human infectious disease. Nat Rev Genet 2001, 2:967-977.
12. Courtois G., Smahi A., Reichenbach J., et al. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 2003, 112:1108-1115.
13. de Veer M.J., Curtis J.M., Baldwin T.M., et al. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur J Immunol 2003, 33:2822-2831.
14. DiMango E., Zar H.J., Bryan R., et al. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 1995, 96:2204-2210.
15. Doffinger R., Smahi A., Bessia C., et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001, 27:277-285.
16. Du X., Poltorak A., Wei Y., et al. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 2000, 11:362-371.
17. Echchannaoui H., Frei K., Schnell C., Leib S.L., Zimmerli W., Landmann R. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis 2002, 186:798-806.
18. Edelson B.T., Unanue E.R. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J Immunol 2002, 169:3869-3875.
19. Eisenbarth S.C., Piggott D.A., Huleatt J.W., Visintin I., Herrick C.A., Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002, 196:1645-1651.
20. Erridge C.J., Stewart, Poxton I.R. Monocytes heterozygous for the Asp299Gly and Thr399lle mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J Exp Med 2003, 197:1787-1791.
21. Feng C.G., Scanga C.A., Collazo-Custodio C.M., et al. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol 2003, 171:4758-4764.
22. Feterowski C., Emmanuilidis K., Miethke T., et al. Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology 2003, 109:426-431.
23. Fitzgerald K.A., Rowe D.C., Barnes B.J., et al. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 2003, 198:1043-1055.
24. Fraser D.W., Tsai T.R., Orenstein W., et al. Legionnaires disease: description of an epidemic of pneumonia. N Engl J Med 1977, 297:1189-1197.
25. Fremond C.M., et al. Control of Mycobacterium bovis BCG infection with increased inflammation in TLR4-deficient mice. Microbes Infect 2003, 5:1070-1081.
26. Gewirtz A.T., Navas T.A., Lyons S., Godowski P.J., Madara J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001, 167:1882-1885.
27. Hagberg L., Hull R., Hull S., McGhee J.R., Michalek S.M., Svanborg Eden C. Difference in susceptibility to gramnegative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immen 1984, 46:839-844.
28. Hajjar A.M., Arnst R.K., Tsai J.H., Wilson C.B., Miller S.I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 2002, 3:354-359.
29. Hawn T., Verbon R.A., Lettinga K.D., et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' Disease. J Exp Med 2003, 198:1563-1572.
30. Hayashi F., Smith K.D., Ozinsky A., et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptors 5. Nature 2001, 410:1099-1103.
31. Heldwein K.A., et al. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. J Leukoc Biol 2003, 74:277-286.
32. Helmby H., Grencis R.K. Essential role for TLR4 and MyD88 in the development of chronic intestinal nematode infection. Eur J Immunol 2003, 33:2974-2979.
33. Hou L., Sasaki H., Stashenko P. Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection. Infect Immun 2000, 68:4681-4687.
34. Jain A., Ma C.A., Liu S., Brown M., Cohen J., Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2001, 2:223-228.
35. Jarrossay D., Napolitani G., Colonna M., Sallusto F., Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 2001, 31:3388-3393.
36. Kadowski N., Ho S., Antonenko S., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001, 194:863-869.
37. Kamath A.B., et al. Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis. Infect Immun 2003, 71:4112-4118.
38. Kiechl S., Lorenz E., Reindl M., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002, 347:185-192.
39. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86:973-983.
40. Liaudet L., Szabo C., Evgenov O.V., et al. Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis. Shock 2003, 19:131-137.
41. Lien E., Means T.K., Heine H., et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000, 105:497-504.
42. Lorenz E., Mira J.P., Frees K.L., Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002, 162:1028-1032.
43. Malley R., et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. proc Natl Acad Sci USA 2003, 100:1966-1971.
44. Medvedev A.E., Lentschat A., Kuhns D.B., et al. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med 2003, 198:521-531.
45. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
46. Melmed G., Thomas L.S., Lee N., et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 2003, 170:1406-1415.
47. Miettinen M., Sareneva T., Julkunen I., Matikainen S. IFNs activate toll-like receptor gene expression in viral infections. Genes Immun 2001, 2:349-355.
48. Mizel S.B., West A.P., Hantgan R.R. Identification of a sequence in human toll-like receptor 5 required for the binding of Gram-negative flagellin. J Biol Chem 2003, 278:23624-23629.
49. Mun H.S., Aosai F., Norose K., et al. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int Immunol 2003, 15:1081-1087.
50. Muraille E., De Trez C., Brait M., De Baetselier P., Leo O., Carlier Y. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 responses. J Immunol 2003, 170:4237-4241.
51. O'Brien A.D., Rosenstreich D.L., Scher I., Campbell G.H., MacDermott R.P., Formal S.B. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J Immunol 1980, 124:20-24.
52. Okamura Y., Watari M., Jerud E.S., et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001, 276:10229-10233.
53. Ozinsky A., Underhill D.M., Fontenot J.D., et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000, 97:13766-13771.
54. Picard C., Puel A., Bonnet M., et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003, 299:2076-2079.
55. Poltorak A., He X., Smirnova I., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
56. Poltorak A., Ricciardi-Castagnoli P., Citterio S., Beutler B. Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci USA 2000, 97:2163-2167.
57. Pulendran B., Kumar P., Cutler C.W., Mohamadzadeh M., Van Dyke T., Banchereu J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 2001, 167:5067-5076.
58. Reiling N., et al. Cutting edge: Toll-like receptor (TLR)2-and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 2002, 169:3480-3484.
59. Rock F., Hardiman L.G., Timans J.C., Kastelein R.A., Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998, 95:588-593.
60. Scanga C.A., Aliberti J., Jankovic D., et al. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J Immunol 2002, 168:5997-6001.
61. Schnare M., Barton G.M., Holt A.C., Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001, 2:947-950.
62. Seki E., Tsutsui H., Tsuji N.M., et al. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol 2002, 169:3863-3868.
63. Shim T.S., Turner O.C., Orme I.M. Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 2003, 83:367-371.
64. Sierro F., Dubois B., Coste A., Kaiserlian D., Kraehenbuhl J.P., Sirard J.C. Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci USA 2001, 98:13722-13727.
65. Smirnova I., Mann N., Dols A., et al. Assay of locusspecific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci USA 2003, 2:2.
66. Smith K.D., Andersen-Nissen E., Hayashi F., et al. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol 2003, 4:1247-1253.
67. Standiford T.J., Kunkel S.L., Basha M.A., et al. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest 1990, 86:1945-1953.
68. Steiner T.S., Nataro J.P., Poteet-Smith C.E., Smith J.A., Guerrant R.L. Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. J Clin Invest 2000, 105:1769-1777.
69. Sugawara I., et al. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol Immunol 2003, 47:327-336.
70. Sugawara I., et al. Mycobacterial infection in MyD88-deficient mice. Microbiol Immunol 2003, 47:841-847.
71. Suzuki N., Suzuki S., Duncan G.S., et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002, 416:750-756.
72. Takeuchi O., Hoshino K., Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000, 165:5392-5396.
73. Takeuchi O., Kawai T., Sanjo H., et al. TLR6: A novel member of an expanding toll-like receptor family. Gene 1999, 231:59-65.
74. Underhill D.M. Toll-like receptors: networking for success. Eur J Immunol 2003, 33:1767-1775.
75. Underhill D.M., Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002, 14:103-110.
76. von Aulock S., Schroder N.W., Gueinzius K., et al. Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J Infect Dis 2003, 188:938-943.
77. Wang M., Jeng K.C., Ping L.I. Exogenous cytokine modulation or neutralization of interleukin-10 enhance survival in lipopolysaccharide-hyporesponsive C3H/HeJ mice with Klebsiella infection. Immunology 1999, 98:90-97.
78. Wang X., et al. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J Immunol 2002, 168:810-815.
79. Weighardt H., Kaiser-Moore S., Vabulas R.M., Kirschning C.J., Wagner H., Holzmann B. Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection. J Immunol 2002, 169:2823-2827.
80. Westendorp R.G., Langermans J.A., Huizinga T.W., et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997, 349:170-173.
81. Woods J.P., Frelinger J.A., Warrack G., Cannon J.G., et al. Mouse genetic locus Los influences susceptibility to Neisseria meningitidis infection. Infect Immun 1988, 56:1950-1955.
82. Yamamoto M., Sato S., Hemmi H., et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 2003, 4:1144-1150.
83. Yaqoob P., Newsholme E.A., Calder P.C. Comparison of cytokine production in cultures of whole human blood and purified mononuclear cells. Cytokine 1999, 11:600-605.
84. Zonana J., Elder M.E., Schneider L.C., et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 2000, 67:1555-1562.